EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis

Geshani C Bandara iD, Ryann D Boudreau, William Wyatt, Steven R Caliari iD

Journal of Biomedical Materials Research Part A · 2026-02 · 114 (2)

DOI: 10.1002/jbma.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 10.02.2026. Verfasst von Geshani C Bandara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Heparin, Tissue Scaffolds, Muscle Development, Collagen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomaterial‐based skeletal muscle tissue engineering approaches have largely focused on mimicking the 3D aligned architecture of native muscle, which is critical for guiding myotube formation and force transmission. In contrast, fewer studies incorporate glycosaminoglycan (GAG)‐mediated biochemical cues despite their known role in regulating myogenesis and growth factor sequestration. In this study, we develop aligned collagen‐GAG (CG) scaffolds using directional freeze‐drying and systematically vary GAG type by incorporating GAGs of increasing sulfation levels (hyaluronic acid, chondroitin sulfate, and heparin). While all scaffold variants support myoblast adhesion, metabolic activity, and myotube alignment, heparin‐modified CG scaffolds significantly enhance myoblast metabolic activity and myogenic differentiation as measured by myosin heavy chain (MHC) expression and myotube size. We additionally show that heparin‐modified scaffolds sequester and retain significantly higher levels of insulin‐like growth factor‐1 (IGF‐1), a potent promoter of myogenesis, compared to other scaffold groups. Together, these results highlight the importance of tailoring GAG type in CG scaffolds for targeted applications and underscore the promise of heparin‐modified CG scaffolds as a material platform for skeletal muscle tissue engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinTissue ScaffoldsMuscle DevelopmentCollagenAnimalsInsulin-Like Growth Factor ICell DifferentiationMyoblastsMiceCell LineTissue EngineeringGlycosaminoglycansMuscle Fibers, Skeletal

Substanzen

HeparinCollagenInsulin-Like Growth Factor IGlycosaminoglycans

Autor:innen und Institutionen

  • Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Geshani C Bandara, Steven R Caliari

Förderung

  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bandara, G. C., Boudreau, R. D., Wyatt, W., & Caliari, S. R. (2026). Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis. Journal of Biomedical Materials Research Part A, 114(2). https://doi.org/10.1002/jbma.70048

Vancouver

Bandara GC, Boudreau RD, Wyatt W, Caliari SR. Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis. Journal of Biomedical Materials Research Part A. 2026;114(2). doi:10.1002/jbma.70048

BibTeX
@article{Bandara2026,
  author = {Bandara, Geshani C and Boudreau, Ryann D and Wyatt, William and Caliari, Steven R},
  title = {Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  volume = {114},
  number = {2},
  doi = {10.1002/jbma.70048}
}
Kostenlos starten →